| Tracking the evolution of non–small-cell lung cancer M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ... New England Journal of Medicine 376 (22), 2109-2121, 2017 | 2392 | 2017 |
| Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ... Nature 545 (7655), 446-451, 2017 | 1880 | 2017 |
| Allele-specific HLA loss and immune escape in lung cancer evolution N McGranahan, R Rosenthal, CT Hiley, AJ Rowan, TBK Watkins, ... Cell 171 (6), 1259-1271. e11, 2017 | 1308 | 2017 |
| Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis S Turajlic, K Litchfield, H Xu, R Rosenthal, N McGranahan, JL Reading, ... The lancet oncology 18 (8), 1009-1021, 2017 | 949 | 2017 |
| Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal S Turajlic, H Xu, K Litchfield, A Rowan, T Chambers, JI Lopez, D Nicol, ... Cell 173 (3), 581-594. e12, 2018 | 798 | 2018 |
| Meta-analysis of tumor-and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition K Litchfield, JL Reading, C Puttick, K Thakkar, C Abbosh, R Bentham, ... Cell 184 (3), 596-614. e14, 2021 | 722 | 2021 |
| Metastasis as an evolutionary process S Turajlic, C Swanton Science 352 (6282), 169-175, 2016 | 668 | 2016 |
| Resolving genetic heterogeneity in cancer S Turajlic, A Sottoriva, T Graham, C Swanton Nature Reviews Genetics 20 (7), 404-416, 2019 | 630 | 2019 |
| Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal S Turajlic, H Xu, K Litchfield, A Rowan, S Horswell, T Chambers, ... Cell 173 (3), 595-610. e11, 2018 | 621 | 2018 |
| Fc effector function contributes to the activity of human anti-CTLA-4 antibodies FA Vargas, AJS Furness, K Litchfield, K Joshi, R Rosenthal, E Ghorani, ... Cancer cell 33 (4), 649-663. e4, 2018 | 599 | 2018 |
| Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal TJ Mitchell, S Turajlic, A Rowan, D Nicol, JHR Farmery, T O’Brien, ... Cell 173 (3), 611-623. e17, 2018 | 524 | 2018 |
| SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma SJ Furney, M Pedersen, D Gentien, AG Dumont, A Rapinat, L Desjardins, ... Cancer discovery 3 (10), 1122-1129, 2013 | 515 | 2013 |
| The 2022 World Health Organization classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours H Moch, MB Amin, DM Berney, EM Compérat, AJ Gill, A Hartmann, ... European urology 82 (5), 458-468, 2022 | 509 | 2022 |
| Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ... Immunity 46 (4), 577-586, 2017 | 464 | 2017 |
| Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma MR Girotti, M Pedersen, B Sanchez-Laorden, A Viros, S Turajlic, ... Cancer discovery 3 (2), 158-167, 2013 | 425 | 2013 |
| Pervasive chromosomal instability and karyotype order in tumour evolution TBK Watkins, EL Lim, M Petkovic, S Elizalde, NJ Birkbak, GA Wilson, ... Nature 587 (7832), 126-132, 2020 | 337 | 2020 |
| Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature L Spain, G Walls, M Julve, K O’Meara, T Schmid, E Kalaitzaki, S Turajlic, ... Annals of Oncology 28 (2), 377-385, 2017 | 266 | 2017 |
| Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma SJ Furney, S Turajlic, G Stamp, M Nohadani, A Carlisle, JM Thomas, ... The Journal of pathology 230 (3), 261-269, 2013 | 232 | 2013 |
| Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium RN Amaria, AM Menzies, EM Burton, RA Scolyer, MT Tetzlaff, ... The Lancet Oncology 20 (7), e378-e389, 2019 | 226 | 2019 |
| The 2022 World Health Organization classification of tumors of the urinary system and male genital organs—part B: prostate and urinary tract tumors GJ Netto, MB Amin, DM Berney, EM Compérat, AJ Gill, A Hartmann, ... European urology 82 (5), 469-482, 2022 | 206 | 2022 |
